ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma.

[1]  C. Bradford,et al.  Advances and applications of oral cancer basic research. , 2011, Oral oncology.

[2]  Brian J. Wilson,et al.  ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. , 2011, Cancer research.

[3]  V. Bertholet,et al.  Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma , 2011, Head & neck.

[4]  M. Grimm,et al.  Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa. , 2011, Cancer biomarkers : section A of Disease markers.

[5]  Björn Friedrich,et al.  MSCA-1/TNAP Selection of Human Jaw Periosteal Cells Improves their Mineralization Capacity , 2011, Cellular Physiology and Biochemistry.

[6]  Vinitha Richard,et al.  The stem cell code in oral epithelial tumorigenesis: 'the cancer stem cell shift hypothesis'. , 2010, Biochimica et biophysica acta.

[7]  M. Wicha,et al.  Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. , 2010, Cancer research.

[8]  M. Grimm,et al.  MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status , 2010, Journal of Translational Medicine.

[9]  Manuel Hidalgo,et al.  Tumor-initiating cells are rare in many human tumors. , 2010, Cell stem cell.

[10]  M. Wicha,et al.  Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase , 2010, Head & neck.

[11]  I. Mackenzie,et al.  Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance , 2010, BMC Cancer.

[12]  Yi-Wei Chen,et al.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. , 2009, Biochemical and biophysical research communications.

[13]  M. Dean.  ABC Transporters, Drug Resistance, and Cancer Stem Cells , 2009, Journal of Mammary Gland Biology and Neoplasia.

[14]  S. Morrison,et al.  Efficient tumor formation by single human melanoma cells , 2008, Nature.

[15]  B. Mack,et al.  CD44s and CD44v6 Expression in Head and Neck Epithelia , 2008, PloS one.

[16]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[17]  D. Alexander,et al.  Analysis of OPLA scaffolds for bone engineering constructs using human jaw periosteal cells , 2008, Journal of materials science. Materials in medicine.

[18]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[19]  Aleksandar Dakic,et al.  Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.

[20]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[21]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[22]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[23]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[24]  J. Dick,et al.  Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity , 2004, Nature Immunology.

[25]  M. van Glabbeke,et al.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.

[26]  J. Jacobs,et al.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.

[27]  R. Friedrich,et al.  Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma. , 2004, In vivo.

[28]  I. Mackenzie.  Growth of malignant oral epithelial stem cells after seeding into organotypical cultures of normal mucosa. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[29]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Stringaro,et al.  Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells. , 2002, Current protein & peptide science.

[31]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[32]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[33]  J. Tobias,et al.  Has chemotherapy proved itself in head and neck cancer? , 1990, British Journal of Cancer.

[34]  D M Parkin,et al.  Estimates of the worldwide frequency of sixteen major cancers in 1980 , 1988, International journal of cancer.

[35]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[36]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[37]  J. Nör,et al.  The biology of head and neck cancer stem cells. , 2012, Oral oncology.

[38]  R. Elble,et al.  The role of cancer stem cells in relapse of solid tumors. , 2012, Frontiers in bioscience.

[39]  A. Scarpa,et al.  Pathology and Genetics , 2010 .

[40]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[41]  D. Cox.  Regression Models and Life-Tables , 1972 .